Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Ochi A"'
Autor:
Hirokazu Kaneko, Hideaki Miyake, Masahiro Nozawa, Kazuyuki Numakura, Go Kimura, Suguru Shirotake, Hirotsugu Uemura, Kazutoshi Yamana, Yasutomo Nakai, Satoru Masui, Satoshi Fukasawa, Takahiro Osawa, Nobuyuki Hinata, Teruo Inamoto, Toru Etsunaga, Junji Yonese, Kosuke Ueda, Motohide Uemura, Kenya Ochi, Katsunori Tatsugami
Publikováno v:
International Journal of Clinical Oncology
Background In a phase III clinical trial, CheckMate 025, treatment of metastatic renal cell carcinoma (mRCC) with nivolumab demonstrated superior efficacy over everolimus. However, as the clinical trial excluded patients with specific complications a
Autor:
Azusa Akiyama, Keiko Nishida, Yoshihiko Hosokawa, Ayumi Shikama, Hiroyuki Ochi, Nobutaka Tasaka, Takeo Minaguchi, Wataru Takao, Toyomi Satoh, Manabu Sakurai
Publikováno v:
International journal of clinical oncology. 24(10)
The selection criteria for secondary cytoreductive surgery (SCS) for recurrent endometrial cancer (EC) remain to be defined. The present study aimed to identify predictors for favorable survival after SCS for the disease. We retrospectively reviewed
Autor:
Hiromitsu Kanzaki, N. Nishijima, Masaaki Kataoka, Takashi Ochi, Teruhito Mochizuki, Atsushi Nishikawa, K. Uwatsu, Kei Nagasaki
Publikováno v:
International Journal of Clinical Oncology. 21:853-861
We retrospectively investigated the impact on survival of early tumor reduction during definitive radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC) patients, according to their histological subtypes. Between November 2006 and D
Publikováno v:
Surgical Oncology. 24:194-199
Purpose The histological assessment of tumor necrosis of the excised lesion after neoadjuvant chemotherapy is the most important prognostic factor for patients with osteosarcoma, but more early prognostic factors are needed for the adjustment of adju
Autor:
Akiko Matsushita, Yotaro Ochi, Hisako Hashimoto, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Takayuki Ishikawa, Tomohiro Yabushita, Yukihiro Imai, Shuichiro Kaji, Yuichiro Ono, Daisuke Katoh
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(12)
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have a poor prognosis, even in the rituximab era. Several studies have reported the clinical importance of the peripheral blood lymphocyte-to-monocyte ratio (LMR) in various mali
Autor:
Kazuhiro Nakamura, Hiroyuki Ochi, Toyomi Satoh, Keiichi Fujiwara, Shoji Nagao, Hiroyuki Fujiwara, Masashi Takano, Takashi Minegishi, Kiyoshi Ito, Harushige Yokota, Morikazu Miyamoto, Y Kaneta, Hiroyuki Yoshikawa, Mitsuaki Suzuki, A Kurosaki, Kenichi Furuya, Yuji Takei, Y Hasumi
Publikováno v:
British Journal of Cancer
Background: Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. Methods: The patients with endometrial adenocarcin
Autor:
Akihiko Ozaki, Takeru Yokota, Sae Ochi, Shigehira Saji, Tetsuya Tanimoto, Claire Leppold, Masahiro Kami, Masaharu Tsubokura, Hiromichi Ohira, Toyoaki Sawano, Yukio Kanazawa, Manabu Tsukada, Shuhei Nomura, Tomohiro Morita, Shigeaki Kato, Tsuyoshi Nemoto
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
Background Little information is available concerning how patient delay may be affected by mass disasters. The main objectives of the present study are to identify whether there was a post-disaster increase in the risk of experiencing patient delay a
Publikováno v:
The Journal of bone and joint surgery. American volume. 93(6):519-526
Background: A large-scale randomized trial of adjuvant interferon-a therapy for patients with osteosarcoma has been initiated as a joint protocol by the European and American Osteosarcoma Study Group. Because the expression of functional interferon-
Autor:
Masahiro Tabata, Yoshiro Fujiwara, Katsuyuki Kiura, Nagio Takigawa, Katsuyuki Hotta, Isao Oze, Mitsune Tanimoto, Nobuaki Ochi
Publikováno v:
Annals of Oncology. 20:829-834
Background The duration of, resources required for and cost of clinical trials could be reduced if a surrogate end point was to be used in place of survival. We assessed the extent to which the objective response rate (ORR) is predictive of mortality
Autor:
Hitoshi Funahashi, Hirozumi Sawai, Hiromitsu Takeyama, Donghui Xu, Yoichi Matsuo, Hiroki Takahashi, Nobuo Ochi, Jiachi Ma, Akira Yasuda
Publikováno v:
Journal of Surgical Oncology. 99:361-367
Background and Objectives Interleukin (IL)-1α plays an important role in colon cancer progression and angiogenesis. We here asked whether IL-1α derived from cancer cells modulates vascular endothelial cell growth, migration and tubule formation. Me